Long term results of percutaneous transluminal valvuloplasty in patients with valvular aortic stenosis.

dc.contributor.authorKale, P Aen_US
dc.contributor.authorSathe, S Ven_US
dc.contributor.authorRajani, R Men_US
dc.contributor.authorLokhandwala, Y Yen_US
dc.contributor.authorSilva, S Den_US
dc.contributor.authorMehan, V Ken_US
dc.contributor.authorKaneria, V Ken_US
dc.contributor.authorKulkarni, H Len_US
dc.contributor.authorDalvi, B Ven_US
dc.date.accessioned1992-03-01en_US
dc.date.accessioned2009-05-27T04:22:23Z
dc.date.available1992-03-01en_US
dc.date.available2009-05-27T04:22:23Z
dc.date.issued1992-03-01en_US
dc.description.abstractThe results of percutaneous balloon aortic valvuloplasty (PBAV) in 62 consecutive patients with valvular aortic stenosis are reported. The age of the patients ranged from 11 months to 72 years (mean 28 +/- 12 years). Hemodynamically successful dilatation was achieved in 58 out of 62 patients. This was associated with marked clinical improvement in these patients. The left ventricular aortic peak to peak gradient decreased from 96.67 +/- 38.4 to 28.14 +/- 26.5mmHg (p < 0.01). There were no deaths during the procedure. Only one patient died in the hospital during the same admission. There was an increase in aortic regurgitation (AR) by at least one grade in 25 (40.3%) patients. Femoral arterial thrombosis was seen in 9/62 patients, 5 of them requiring surgical intervention. Follow up was available in 28 (45.1%) patients over a period of 2-15 months (mean 9 +/- 3 months). Two patients died during the follow up period. Doppler evaluation of gradients was done in all 28 patients with 15 consenting to undergo repeat cardiac catheterisation. Although hemodynamically the restenosis rate was 35.7% (10/28), only 2 of these patients showed symptomatic deterioration. The success of dilatation and restenosis rate were independent of the etiology of aortic stenosis, presence of calcification and the number of balloons used. This study demonstrates that PBAV is feasible in valvular aortic stenosis at low risk and is able to produce significant clinical and hemodynamic improvement in most cases with a restenosis rate of 35.7% at a follow up period of 9 +/- 3 months.en_US
dc.description.affiliationDepartment of Cardiology, King Edward VII Memorial Hospital, Bombay.en_US
dc.identifier.citationKale PA, Sathe SV, Rajani RM, Lokhandwala YY, Silva SD, Mehan VK, Kaneria VK, Kulkarni HL, Dalvi BV. Long term results of percutaneous transluminal valvuloplasty in patients with valvular aortic stenosis. Indian Heart Journal. 1992 Mar-Apr; 44(2): 67-70en_US
dc.identifier.urihttps://imsear.searo.who.int/handle/123456789/4261
dc.language.isoengen_US
dc.source.urihttps://indianheartjournal.comen_US
dc.subject.meshAdolescenten_US
dc.subject.meshAdulten_US
dc.subject.meshAgeden_US
dc.subject.meshAortic Valve Stenosis --physiopathologyen_US
dc.subject.meshBalloon Dilatationen_US
dc.subject.meshChilden_US
dc.subject.meshChild, Preschoolen_US
dc.subject.meshFemaleen_US
dc.subject.meshFollow-Up Studiesen_US
dc.subject.meshHemodynamicsen_US
dc.subject.meshHumansen_US
dc.subject.meshInfanten_US
dc.subject.meshMaleen_US
dc.subject.meshMiddle Ageden_US
dc.subject.meshRecurrenceen_US
dc.subject.meshTreatment Outcomeen_US
dc.titleLong term results of percutaneous transluminal valvuloplasty in patients with valvular aortic stenosis.en_US
dc.typeJournal Articleen_US
Files
License bundle
Now showing 1 - 1 of 1
No Thumbnail Available
Name:
license.txt
Size:
1.79 KB
Format:
Plain Text
Description: